Jiangsu Lianhuan Pharmaceutical Co Ltd Capital Reinvestment Ratio
Jiangsu Lianhuan Pharmaceutical Co Ltd capital reinvestment ratio. Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Capital Reinvestment Ratio of 0.39x as of September 2024, meaning it reinvests 0% of its operating cash flow (CN¥51.50 Million) in capital expenditures (CN¥19.88 Million). See how much free cash does Jiangsu Lianhuan Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Capital reinvestment ratio of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2002 to 2024. This chart tracks Jiangsu Lianhuan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 20 annual periods. See how financially flexible is Jiangsu Lianhuan Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Jiangsu Lianhuan Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2002–2024)
Jiangsu Lianhuan Pharmaceutical Co Ltd capital reinvestment ratio by year from 2002 to 2024. For the full cash flow conversion analysis, see Jiangsu Lianhuan Pharmaceutical Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 17.17x | CN¥10.77 Million | CN¥184.84 Million | ▲ +1275.0% |
| 2023 | 1.25x | CN¥160.70 Million | CN¥200.66 Million | ▼ -23.8% |
| 2022 | 1.64x | CN¥127.59 Million | CN¥209.02 Million | ▲ +34.2% |
| 2021 | 1.22x | CN¥138.34 Million | CN¥168.92 Million | ▼ -35.6% |
| 2020 | 1.89x | CN¥91.94 Million | CN¥174.18 Million | ▼ -85.8% |
| 2017 | 13.38x | CN¥3.64 Million | CN¥48.64 Million | ▲ +1934.6% |
| 2016 | 0.66x | CN¥70.28 Million | CN¥46.21 Million | ▲ +49.0% |
| 2015 | 0.44x | CN¥62.12 Million | CN¥27.41 Million | ▲ +31.2% |
| 2014 | 0.34x | CN¥69.50 Million | CN¥23.37 Million | ▼ -59.5% |
| 2013 | 0.83x | CN¥37.17 Million | CN¥30.85 Million | ▲ +123.3% |
| 2012 | 0.37x | CN¥16.94 Million | CN¥6.30 Million | ▼ -53.0% |
| 2011 | 0.79x | CN¥24.00 Million | CN¥18.98 Million | ▼ -35.0% |
| 2010 | 1.22x | CN¥8.43 Million | CN¥10.26 Million | ▲ +26.8% |
| 2009 | 0.96x | CN¥13.83 Million | CN¥13.29 Million | ▼ -44.6% |
| 2008 | 1.73x | CN¥17.44 Million | CN¥30.25 Million | ▼ -1.0% |
| 2007 | 1.75x | CN¥8.03 Million | CN¥14.08 Million | ▼ -49.5% |
| 2006 | 3.47x | CN¥10.14 Million | CN¥35.19 Million | ▲ +4.9% |
| 2005 | 3.31x | CN¥3.82 Million | CN¥12.65 Million | ▲ +114.2% |
| 2004 | 1.54x | CN¥3.39 Million | CN¥5.24 Million | ▲ +397.1% |
| 2002 | 0.31x | CN¥19.22 Million | CN¥5.97 Million | — |